Table 1 Anticancer drugs for hematological malignancies
From: Liver resection for hepatocellular carcinoma in patients with hematological malignancies
Hematologic malignancy | Anticancer drugs |
|---|---|
Non-Hodgkin’s lymphoma | |
Slowly indolent lymphoma | Modest chemotherapy |
Aggressive lymphoma | Intensive chemotherapy |
Diffuse large B cell lymphoma | Standard first-line chemotherapy |
Rituximab plus CHOP (cyclophosphamide, vincristine, doxorubicin, prednisolone) | |
Multiple myeloma | 1st-line thalidomide; ASCT (autologous stem cell transplant) |
2nd-line bortezomib (Velcade), thalidomide, dexamethasone | |
Lenalidomide | |
Chronic lymphocytic leukemia | CVP (cyclophosphamide, vincristine, prednisolone) |
Bendamustine, rituximab, fludarabine | |
Acute myeloid leukemia | Cytosine arabinoside |
Idarubicin | |